YOLFTbeta
Wuhan Thalys Med Tech Co Ltd

Wuhan Thalys Med Tech Co Ltd

603716 · SHG · Healthcare / Diagnostics & Research

15.02CNY-0.92 (-5.77%)

Price History

Full chart

Market Stats

Previous Close15.94
Open15.84
Day Range14.99 – 15.93
52-Week Range12.92 – 31.86
Volume14.53M
Market Cap3.75B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.97
Dividend Yield0.00%
Beta0.32
50-Day Avg16.57
200-Day Avg19.65

About

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. The company offers fully automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. It also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Corporation in September 2020. Thalys Medical Technology Group Corporation was founded in 2004 and is headquartered in Wuhan, China.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Zheng Wang
  • Employees1.04K
  • HeadquartersNo. 1310 Jinshan Avenue, Wuhan, China, 430040, China
  • Websitehttps://www.thalys.net.cn

Leadership

  • Mr. Zheng WangGM & Director · b. 1967
  • Ms. Yan ShenChief Financial Officer · b. 1977
  • Ms. Li FanDeputy GM, Secretary of the Board & Director · b. 1981
  • Mr. Yi LuDeputy GM & Employee Director · b. 1981
  • Si Yan HuangAccounting Supervisor
  • Mr. Jun SunAdministrative Director · b. 1969
  • Mr. Feng LiuGM of SPD Business & Regional Inspection Center Business Department and Deputy GM · b. 1975

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue193.74M283.17M392.18M445.05M529.66M627.33M920.52M1.32B1.83B2.13B2.60B2.31B2.01B1.81B1.08B
Growth (%)-+46.16%+38.50%+13.48%+19.01%+18.44%+46.74%+43.12%+38.96%+16.10%+22.30%-11.19%-13.10%-9.74%-40.52%
Cost of Revenue110.91M175.67M246.43M281.45M342.41M408.85M610.44M901.34M1.31B1.64B2.06B1.86B1.62B1.48B836.63M
Gross Profit82.83M107.50M145.75M163.59M187.25M218.48M310.08M416.11M519.82M486.83M542.74M448.96M389.74M328.54M240.33M
Gross Margin42.75%37.96%37.16%36.76%35.35%34.83%33.68%31.58%28.39%22.90%20.88%19.45%19.43%18.14%22.32%
Operating Expense32.72M53.68M78.10M87.46M104.12M123.93M171.09M257.47M332.36M369.89M558.94M597.48M570.06M470.34M298.37M
Operating Income50.12M53.82M67.64M76.14M83.13M94.55M138.98M158.64M187.46M116.94M-16.20M-148.53M-180.32M-141.79M-58.04M
Operating Margin25.87%19.01%17.25%17.11%15.69%15.07%15.10%12.04%10.24%5.50%-0.62%-6.43%-8.99%-7.83%-5.39%
EBITDA60.47M65.58M93.81M106.88M122.88M142.72M198.23M247.47M300.01M243.16M132.86M-30.88M-63.82M-55.51M-74.79M
EBITDA Margin31.21%23.16%23.92%24.02%23.20%22.75%21.54%18.78%16.39%11.44%5.11%-1.34%-3.18%-3.07%-6.94%
Net Income37.78M38.33M49.06M56.52M61.46M68.92M93.85M94.16M110.42M57.56M-49.51M-153.73M-158.57M-209.24M-207.28M
Net Income Margin19.50%13.54%12.51%12.70%11.60%10.99%10.20%7.15%6.03%2.71%-1.90%-6.66%-7.90%-11.56%-19.25%
R&D718.00K691.50K1.92M4.09M8.30M7.89M5.09M7.48M10.52M19.53M35.47M29.45M43.21M47.11M41.78M
R&D as % of Total Revenue0.37%0.24%0.49%0.92%1.57%1.26%0.55%0.57%0.57%0.92%1.36%1.28%2.15%2.60%3.88%
Interest Expense781.01K04.03M4.52M7.87M8.94M10.93M32.14M47.64M58.49M84.96M100.09M76.19M58.36M33.53M
Interest Expense % of Total Revenue0.40%0.00%1.03%1.01%1.49%1.43%1.19%2.44%2.60%2.75%3.27%4.34%3.80%3.22%3.11%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets314.16M388.80M437.79M537.57M663.27M1.09B1.57B2.58B3.01B3.91B4.29B3.95B3.34B2.83B1.80B
Total Liabilities60.25M92.30M91.82M131.58M192.97M233.19M565.62M957.21M1.39B2.10B2.55B2.45B2.03B1.87B897.96M
Total Equity252.00M293.66M342.73M399.25M460.70M843.61M933.39M1.52B1.49B1.65B1.56B1.40B1.21B934.29M944.69M
Cash64.12M50.91M50.16M66.49M96.72M353.78M196.50M702.88M508.11M661.75M473.55M394.54M278.59M209.44M130.94M
Total Debt19.80M44.51M49.85M83.88M124.02M167.78M338.51M690.42M881.52M1.40B1.62B1.44B1.04B900.43M-
Net Debt-44.31M-6.40M-312.75K17.39M27.30M-186.01M142.01M-12.46M373.41M737.19M1.15B1.04B761.86M691.00M102.49M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-24.22M2.70M32.54M30.07M46.11M-17.02M-63.25M-63.83M93.92M9.94M-133.52M28.12M125.89M99.60M-37.75M
Investing Cash Flow-31.64M-41.46M-34.34M-49.49M-40.47M-69.04M-248.59M-228.79M-282.40M-288.98M-114.72M159.71M15.19M-7.67M-
Financing Cash Flow112.80M25.55M1.05M30.76M24.59M342.96M154.56M775.87M4.72M440.95M61.39M-316.64M-214.31M-148.27M-
Capital Expenditure28.71M41.04M34.35M31.73M40.47M69.04M116.01M118.54M96.49M127.70M60.19M54.64M40.83M23.21M5.72M
Free Cash Flow-52.93M-38.34M-1.81M-1.67M5.64M-86.05M-179.26M-182.37M-2.57M-117.76M-193.71M-26.52M85.06M76.39M-43.47M
Dividends Paid1.22M2.40M3.84M4.24M7.30M7.52M14.73M37.22M50.10M15.87M49.52M52.25M38.80M59.88M18.56M
FCF to OCF218.56%-1420.45%-5.57%-5.55%12.23%505.72%283.41%285.72%-2.73%-1184.19%145.08%-94.31%67.57%76.70%115.15%
Dividend Paid to FCF-2.31%-6.25%-211.83%-254.15%129.46%-8.74%-8.21%-20.41%-1951.43%-13.47%-25.56%-197.01%45.61%78.39%-42.69%

Earnings

Report DateJan 24, 2017Apr 29, 2017Aug 31, 2017Oct 31, 2017Feb 6, 2018Apr 28, 2018Aug 5, 2018Oct 29, 2018Dec 31, 2018Apr 25, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Aug 20, 2020Oct 30, 2020Dec 31, 2020Apr 29, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 20, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------
EPS Actual0.110.080.130.100.220.100.170.110.120.110.170.160.11-0.130.170.110.150.03-0.01-0.01-0.260.11-0.10-0.04-0.78-0.080.09-0.03-0.820.02-0.04-0.27-0.82-0.08-0.22-0.15-0.58-0.08-0.14
Surprise---------------------------------------
TimingPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-market-----------------------After-hours-----

Key Statistics & Ratios

Market Cap3.75B
Enterprise Value3.95B
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.49
Price / Book3.47
EPS-0.97
Book Value4.93
Revenue (TTM)836.23M
Gross Profit (TTM)171.84M
EBITDA-64.89M
Profit Margin-23.80%
Operating Margin-16.26%
Return on Equity-21.49%
Return on Assets-2.92%
Shares Outstanding225.79M
Shares Float189.76M
Beta0.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20201×
0.08Jun 18, 2020
20181×
0.10Apr 25, 2018
20171×
0.02Apr 7, 2017

Stock Splits

  • Apr 25, 20185:2
  • Oct 23, 20177:5